300181 Zhejiang Jolly Pharmaceutical
- 15.79
- +0.29+1.87%
Zhejiang Jolly Pharmaceutical News
Zuoli Pharmaceutical: Announcement on the “Double Improvement of Quality and Return” action plan
Zhejiang Jolly Pharmaceutical: Zhejiang Jolly Pharmaceutical Co., Ltd.'s summary table of non-operational fund utilization and other related fund transactions for the first half of 2024.
Zhejiang Jolly Pharmaceutical: Interim report disclosure prompt announcement for 2024.
Zhejiang Jolly Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Zhejiang Jolly Pharmaceutical: Announcement on the completion of the election of the Board of Directors and the Board of Supervisors and the appointment of senior managers, heads of audit departments, and representatives of securities affairs
Zhejiang Jolly Pharmaceutical: Legal Opinion of Shanghai Oriental Huayin Law Firm on the 2023 Annual General Meeting of Shareholders of Zhejiang Zuoli Pharmaceutical Co., Ltd.
Zhejiang Jolly Pharmaceutical: Notice on the company's senior management receiving the Zhejiang Securities Regulatory Bureau's regulatory dialogue measures decision
Zuoli Pharmaceutical: 2023 Internal Control Self-Assessment Report
Zuoli Pharmaceutical: Working System for Special Meetings of Independent Directors
Zuoli Pharmaceutical: Announcement on the Notice of Convening the 2023 Annual General Meeting of Shareholders
Zuoli Pharmaceutical: Special note by the board of directors on the retroactive adjustment of financial statements
Zuli Pharmaceuticals: 2023 Financial Results Report
Zuoli Pharmaceutical: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Zuoli Pharmaceutical: Opinions of the Seventh Board of Directors Nomination Committee on the Eligibility of Independent Director Candidates for the Eighth Board of Directors
Zuli Pharmaceutical: Notice on Using Some Idle Funds Raised and Idle Own Funds for Cash Management
Zuoli Pharmaceuticals: Board of Directors Rules of Procedure
Zuoli Pharmaceuticals: Prompt Announcement on Report Disclosure for the First Quarter of 2024
Zuoli Pharmaceuticals: Prompt Announcement for Disclosure of the 2023 Annual Report
Zuoli Pharmaceuticals: Accounting Services Selection and Employment System
Zuli Pharmaceutical: Announcement on the Election of Staff Representative Supervisors for the Eighth Board of Supervisors by the Workers' Congress
Analysis
Price Target
No Data
No Data